- Home
- ONCH vs AVTX Comparison
ONCH vs AVTX Comparison
Compare ONCH & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$14.38
Company Overview
Basic Information| Metric | ONCH | AVTX |
|---|---|---|
| Founded | 2024 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.8M | 248.3M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ONCH | AVTX |
|---|---|---|
| Price | $10.19 | $14.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $34.50 |
| AVG Volume (30 Days) | 79.7K | ★ 369.7K |
| Earning Date | 01-01-0001 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $192,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.16 | $3.39 |
| 52 Week High | $10.63 | $20.72 |
Technical Indicators
Market Signals| Indicator | ONCH | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 37.17 |
| Support Level | $10.18 | $13.04 |
| Resistance Level | $10.22 | $16.15 |
| Average True Range (ATR) | 0.03 | 1.09 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 52.94 | 14.85 |
Price Performance
Historical Comparison ONCH
AVTX
About ONCH 1RT Acquisition Corp. Class A Ordinary Share
1RT Acquisition Corp is a blank check company.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).